Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability
Firsov, A.A.; Piotrovskii, V.K.
Die Pharmazie 41(7): 457-465
1986
ISSN/ISBN: 0031-7144 PMID: 3534896 Document Number: 268320
Document emailed within 1 workday
Related Documents
Rajaram, L.; Roy, S.K.; Skerjanec, A. 2004: Bioavailability and bioequivalence trials: statistics and pharmacokinetic principles Studies in Health Technology and Informatics 103: 159-179Liu, H.-C.; Hwu, C.-S.; Hung, J.-M.; Lai, H.-Y.; Chang, H.-Y.; Lu, C.-J. 2011: Reliability of solid phase microextraction in estimating bioavailability of pyrene in soil Journal of Environmental Biology 32(3): 319-323
Bergan, T. 1993: Pharmacokinetic profile of brodimoprim: oral bioavailability and penetration into interstitial fluid Journal of ChemoTherapy 5(6): 488-489
Zwolska, Z.; Augustynowicz-Kopeć, E.; Niemirowska-Mikulska, H. 2002: The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule Acta Poloniae Pharmaceutica 59(6): 448-452
de Boer, A.G.; Röst-Kaiser, J.; Bracht, H.; Breimer, D.D. 1978: Assay of underivatized intrazepam and clonazepam in plasma by capillary gas chromatography applied to pharmacokinetic and bioavailability studies in humans Journal of Chromatography 145(1): 105-114
Szyszka, A.; Kaźmierczak, E.; Dziegielewska, G.; Lowicki, Z.; Mrozikewicz, A. 1994: Assessment of bioavailability of magnesium preparations Wiadomosci Lekarskie 47(13-14): 481-483
Coleman, J.H.; Straughn, A.B. 1975: Assurance of drug quality (bioavailability) Diseases of the Nervous System 36(2): 63-64
Suthisisang, C.; Payakachat, N. 1998: Bioavailability of phenytoin sodium capsules available in Thailand. Part I: In vitro study Journal of the Medical Association of Thailand 81(1): 58-63
Suthisisang, C.; Payakachat, N.; Chulavatnatol, S.; Towanabut, S. 1998: Bioavailability of phenytoin sodium capsules available in Thailand. Part II: in vivo study Journal of the Medical Association of Thailand 81(1): 64-70
Messori, A.; Rosselli, P. 1984: A calculator program for estimating model-independent pharmacokinetic parameters Bollettino Chimico Farmaceutico 123(11): 530-538
Batuashvili, T.A.; Shchedrin, V.I.; Zak, A.F. 1979: Bioavailability of peroral drug forms of oxacillin Antibiotiki 24(8): 611-615
Alighieri, T.; Avanessian, S.; Berlini, S.; Bianchi, S.G.; Deluigi, P.; Valducci, R.; Guelen, P.J. 1988: Bioavailability of ambroxol sustained release preparations. Part I: In vitro dissolution studies Arzneimittel-Forschung 38(1): 92-94
Hofmann, B.; Reinecke, I.; Schuett, B.; Merz, M.; Zurth, C. 2014: Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive International Journal of Clinical Pharmacology and Therapeutics 52(12): 1059-1070
Cabana, B.E. 1976: Application and contribution of animal models in drug bioavailability Psychopharmacology Bulletin 12(4): 51-54
Cascioli, D.; Petrangeli, B. 1978: Drug absorption and bioavailability problems of tablets and capsules Bollettino Chimico Farmaceutico 117(8): 437-451
Mallick, S.; Gupta, B.K.; Ghosal, S.K. 2000: Assessment of bioavailability of experimental controlled release microcapsules of nifedipine Acta Poloniae Pharmaceutica 57(3): 175-180
Raspopov, R.V.; Buzulukov, I.P.; Marchenkov, N.S.; Solov'ev, V.Iu.; Demin, V.F.; Kalistratova, V.S.; Gmoshinskiĭ, I.V.; Khotimchenko, S.A. 2010: The bioavailability of zinc oxide nanoparticles. Study using methods of radionuclide indicators Voprosy Pitaniia 79(6): 14-18
Rui, J.Z.; Cai, M.H.; Chu, X.M.; Chen, G. 1995: NONMEM approach for estimating population pharmacokinetic parameters of phenytoin in Chinese epileptics Yao Xue Xue Bao 30(3): 172-178
Janssen, T.J.; Guelen, P.J.; Vree, T.B.; Botterblom, M.H.; Valducci, R. 1988: Bioavailability of ambroxol sustained release preparations. Part II: Single and multiple oral dose studies in man Arzneimittel-Forschung 38(1): 95-97
Venho, V.M.; Palva, E.S.; Konno, K.; Stenfors, E. 1987: The value of comparative bioavailability studies of marketed drugs in drug control. An example with erythromycin stearate Methods and Findings in Experimental and Clinical Pharmacology 9(7): 445-447